Research & Development
Cue's Molecular Point-of-Care COVID-19 Tests Now Available in 10 States Under US Health and Human Services, Department of Defense Pilot Program
19 January 2021 - - US-based medical diagnostic products provider Cue Health Inc's molecular, point-of-care COVID-19 Tests are being distributed to five additional states, including Col...
European Medicines Agency grants PRIME designation to Tessa Therapeutics' lead autologous CD30 CAR-T therapy
19 January 2021 - The European Medicines Agency (EMA) has granted PRiority Medicines (PRIME) designation to Singapore-based Tessa Therapeutics' lead autologous CD30 CAR-T therapy intended for the...
Genkyotex SA's Phase 1 study in oral setanaxib demonstrated tolerance at the doses of up to 1600mg/day for treating PBC
18 January 2021 - Genkyotex SA revealed on Friday that its Phase 1 study in oral setanaxib demonstrated tolerance at the doses of up to 1600mg/day, with no safety signal or dose-limiting toxicity bein...
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
18 January 2021 - - The European Medicines Agency has granted PRiority MEdicines (PRIME) designation to US-based clinical-stage cell therapy company Tessa Therapeutics' lead autologous CD30 ...
Janssen Receives FDA Approval of Darzalex Faspro as Treatment for Newly Diagnosed Patients with Light Chain Amyloidosis
18 January 2021 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) Janssen Biotech, Inc. business has received US Food and Drug Administration approval of Darzalex Faspro (daratumu...
Steba biotech receives US FDA Fast Track designation for padeliporfin IMmune Photo Activate Cancer Treatment
18 January 2021 - Luxembourg-based Steba biotech has received Fast Track designation from the United States Food and Drug Administration (FDA) for padeliporfin IMmune Photo Activate Cancer Treatment (...
Related Headlines

Amber Specialty Pharmacy administers Bamlanivimab in long term care facilities in five cities across the US in the battle against COVID-19

Arcus Biosciences Presents Initial Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer

Pfizer's Xalkori Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults

Eurofins Launches New Tests and Massive Capacity for Detecting and Monitoring New Variants of SARS-CoV-2

Applied DNA Advances COVID-19 Diagnostics and Testing Activities

SML Genetree wins FDA's EUA for Ezplex SARS-CoV-2 G PCR Kit with specimen pooling capability

US FDA Clears Vor's IND Application for VOR33

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing

Twist Bioscience Begins Shipping of Synthetic RNA Controls for UK Variant Strain of SARS-CoV-2

Philippines FDA approves Pfizer-BioNTech COVID-19 vaccine for emergency use

Johnson & Johnson's COVID-19 vaccine generates immune response in early trials after single dose

Sana Biotechnology Names Bilenker, Seitz to Board of Directors

Personal Genome Diagnostics Teams with Qiagen to Offer Integrated Genomic Testing and Interpretation Support

Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application for the Use of Ganaxolone in CDKL5 Deficiency Disorder

Celltrion Group Touts Positive Top-Line Efficacy and Safety Data from Global Phase II/III Clinical Trial of COVID-19 Treatment Candidate CT-P59